 | • レポートコード：MRC2-11QY02737 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はオータコイド・関連薬のグローバル市場について調査・分析したレポートです。種類別（ポリペプチド、脱炭酸アミノ酸、エイコサノイド）市場規模、用途別（アレルギー、炎症、胃酸分泌、神経内分泌調節、慢性疼痛、心血管疾患、胃腸疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別オータコイド・関連薬の競争状況、市場シェア ・世界のオータコイド・関連薬市場：種類別市場規模 2015年-2020年（ポリペプチド、脱炭酸アミノ酸、エイコサノイド） ・世界のオータコイド・関連薬市場：種類別市場規模予測 2021年-2026年（ポリペプチド、脱炭酸アミノ酸、エイコサノイド） ・世界のオータコイド・関連薬市場：用途別市場規模 2015年-2020年（アレルギー、炎症、胃酸分泌、神経内分泌調節、慢性疼痛、心血管疾患、胃腸疾患） ・世界のオータコイド・関連薬市場：用途別市場規模予測 2021年-2026年（アレルギー、炎症、胃酸分泌、神経内分泌調節、慢性疼痛、心血管疾患、胃腸疾患） ・北米のオータコイド・関連薬市場分析：米国、カナダ ・ヨーロッパのオータコイド・関連薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのオータコイド・関連薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のオータコイド・関連薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのオータコイド・関連薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bedford Laboratories、Bristol-Myers Squibb、APP Pharma、Abbott Laboratories、Sanofi、Chattem、Xanodyne、AstraZeneca、Hospira ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Autacoids and Related Drugs Market
The global Autacoids and Related Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Autacoids and Related Drugs Scope and Market Size
Autacoids and Related Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Autacoids and Related Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Autacoids and Related Drugs market is segmented into
Polypeptides
Decarboxylated Amino Acids
Eicosanoids
Segment by Application, the Autacoids and Related Drugs market is segmented into
Allergies
Inflammation
Gastric Acid Secretion
Neuroendocrine Regulation
Chronic Pain
Cardiovascular Diseases
Gastrointestinal Diseases
Regional and Country-level Analysis
The Autacoids and Related Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Autacoids and Related Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Autacoids and Related Drugs Market Share Analysis
Autacoids and Related Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Autacoids and Related Drugs business, the date to enter into the Autacoids and Related Drugs market, Autacoids and Related Drugs product introduction, recent developments, etc.
The major vendors covered:
Bedford Laboratories
Bristol-Myers Squibb
APP Pharma
Abbott Laboratories
Sanofi
Chattem
Xanodyne
AstraZeneca
Hospira
1 Study Coverage
1.1 Autacoids and Related Drugs Product Introduction
1.2 Market Segments
1.3 Key Autacoids and Related Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Autacoids and Related Drugs Market Size Growth Rate by Type
1.4.2 Polypeptides
1.4.3 Decarboxylated Amino Acids
1.4.4 Eicosanoids
1.5 Market by Application
1.5.1 Global Autacoids and Related Drugs Market Size Growth Rate by Application
1.5.2 Allergies
1.5.3 Inflammation
1.5.4 Gastric Acid Secretion
1.5.5 Neuroendocrine Regulation
1.5.6 Chronic Pain
1.5.7 Cardiovascular Diseases
1.5.8 Gastrointestinal Diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Autacoids and Related Drugs Market Size, Estimates and Forecasts
2.1.1 Global Autacoids and Related Drugs Revenue 2015-2026
2.1.2 Global Autacoids and Related Drugs Sales 2015-2026
2.2 Global Autacoids and Related Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Autacoids and Related Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Autacoids and Related Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Autacoids and Related Drugs Competitor Landscape by Players
3.1 Autacoids and Related Drugs Sales by Manufacturers
3.1.1 Autacoids and Related Drugs Sales by Manufacturers (2015-2020)
3.1.2 Autacoids and Related Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Autacoids and Related Drugs Revenue by Manufacturers
3.2.1 Autacoids and Related Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Autacoids and Related Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Autacoids and Related Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Autacoids and Related Drugs Revenue in 2019
3.2.5 Global Autacoids and Related Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Autacoids and Related Drugs Price by Manufacturers
3.4 Autacoids and Related Drugs Manufacturing Base Distribution, Product Types
3.4.1 Autacoids and Related Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Autacoids and Related Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Autacoids and Related Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Autacoids and Related Drugs Market Size by Type (2015-2020)
4.1.1 Global Autacoids and Related Drugs Sales by Type (2015-2020)
4.1.2 Global Autacoids and Related Drugs Revenue by Type (2015-2020)
4.1.3 Autacoids and Related Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Autacoids and Related Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Autacoids and Related Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Autacoids and Related Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Autacoids and Related Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Autacoids and Related Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Autacoids and Related Drugs Market Size by Application (2015-2020)
5.1.1 Global Autacoids and Related Drugs Sales by Application (2015-2020)
5.1.2 Global Autacoids and Related Drugs Revenue by Application (2015-2020)
5.1.3 Autacoids and Related Drugs Price by Application (2015-2020)
5.2 Autacoids and Related Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Autacoids and Related Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Autacoids and Related Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Autacoids and Related Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Autacoids and Related Drugs by Country
6.1.1 North America Autacoids and Related Drugs Sales by Country
6.1.2 North America Autacoids and Related Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Autacoids and Related Drugs Market Facts & Figures by Type
6.3 North America Autacoids and Related Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Autacoids and Related Drugs by Country
7.1.1 Europe Autacoids and Related Drugs Sales by Country
7.1.2 Europe Autacoids and Related Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Autacoids and Related Drugs Market Facts & Figures by Type
7.3 Europe Autacoids and Related Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Autacoids and Related Drugs by Region
8.1.1 Asia Pacific Autacoids and Related Drugs Sales by Region
8.1.2 Asia Pacific Autacoids and Related Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Autacoids and Related Drugs Market Facts & Figures by Type
8.3 Asia Pacific Autacoids and Related Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Autacoids and Related Drugs by Country
9.1.1 Latin America Autacoids and Related Drugs Sales by Country
9.1.2 Latin America Autacoids and Related Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Autacoids and Related Drugs Market Facts & Figures by Type
9.3 Central & South America Autacoids and Related Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Autacoids and Related Drugs by Country
10.1.1 Middle East and Africa Autacoids and Related Drugs Sales by Country
10.1.2 Middle East and Africa Autacoids and Related Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Autacoids and Related Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Autacoids and Related Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Bedford Laboratories
11.1.1 Bedford Laboratories Corporation Information
11.1.2 Bedford Laboratories Description and Business Overview
11.1.3 Bedford Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bedford Laboratories Autacoids and Related Drugs Products Offered
11.1.5 Bedford Laboratories Related Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Description and Business Overview
11.2.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Autacoids and Related Drugs Products Offered
11.2.5 Bristol-Myers Squibb Related Developments
11.3 APP Pharma
11.3.1 APP Pharma Corporation Information
11.3.2 APP Pharma Description and Business Overview
11.3.3 APP Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 APP Pharma Autacoids and Related Drugs Products Offered
11.3.5 APP Pharma Related Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Corporation Information
11.4.2 Abbott Laboratories Description and Business Overview
11.4.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Abbott Laboratories Autacoids and Related Drugs Products Offered
11.4.5 Abbott Laboratories Related Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description and Business Overview
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi Autacoids and Related Drugs Products Offered
11.5.5 Sanofi Related Developments
11.6 Chattem
11.6.1 Chattem Corporation Information
11.6.2 Chattem Description and Business Overview
11.6.3 Chattem Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Chattem Autacoids and Related Drugs Products Offered
11.6.5 Chattem Related Developments
11.7 Xanodyne
11.7.1 Xanodyne Corporation Information
11.7.2 Xanodyne Description and Business Overview
11.7.3 Xanodyne Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Xanodyne Autacoids and Related Drugs Products Offered
11.7.5 Xanodyne Related Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Description and Business Overview
11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AstraZeneca Autacoids and Related Drugs Products Offered
11.8.5 AstraZeneca Related Developments
11.9 Hospira
11.9.1 Hospira Corporation Information
11.9.2 Hospira Description and Business Overview
11.9.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hospira Autacoids and Related Drugs Products Offered
11.9.5 Hospira Related Developments
11.1 Bedford Laboratories
11.1.1 Bedford Laboratories Corporation Information
11.1.2 Bedford Laboratories Description and Business Overview
11.1.3 Bedford Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bedford Laboratories Autacoids and Related Drugs Products Offered
11.1.5 Bedford Laboratories Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Autacoids and Related Drugs Market Estimates and Projections by Region
12.1.1 Global Autacoids and Related Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Autacoids and Related Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Autacoids and Related Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Autacoids and Related Drugs Sales Forecast (2021-2026)
12.2.2 North America: Autacoids and Related Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Autacoids and Related Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Autacoids and Related Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Autacoids and Related Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Autacoids and Related Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Autacoids and Related Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Autacoids and Related Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Autacoids and Related Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Autacoids and Related Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Autacoids and Related Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Autacoids and Related Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Autacoids and Related Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Autacoids and Related Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Autacoids and Related Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Autacoids and Related Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Autacoids and Related Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Autacoids and Related Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Autacoids and Related Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Autacoids and Related Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Autacoids and Related Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Autacoids and Related Drugs Market Segments
Table 2. Ranking of Global Top Autacoids and Related Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Autacoids and Related Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Polypeptides
Table 5. Major Manufacturers of Decarboxylated Amino Acids
Table 6. Major Manufacturers of Eicosanoids
Table 7. Global Autacoids and Related Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Autacoids and Related Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Autacoids and Related Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Autacoids and Related Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Autacoids and Related Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Autacoids and Related Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Autacoids and Related Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Autacoids and Related Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Autacoids and Related Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autacoids and Related Drugs as of 2019)
Table 16. Autacoids and Related Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Autacoids and Related Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Autacoids and Related Drugs Price (2015-2020) (USD/Pcs)
Table 19. Autacoids and Related Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Autacoids and Related Drugs Product Type
Table 21. Date of International Manufacturers Enter into Autacoids and Related Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Autacoids and Related Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Autacoids and Related Drugs Sales Share by Type (2015-2020)
Table 25. Global Autacoids and Related Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Autacoids and Related Drugs Revenue Share by Type (2015-2020)
Table 27. Autacoids and Related Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Autacoids and Related Drugs Sales by Application (2015-2020) (K Units)
Table 29. Global Autacoids and Related Drugs Sales Share by Application (2015-2020)
Table 30. North America Autacoids and Related Drugs Sales by Country (2015-2020) (K Units)
Table 31. North America Autacoids and Related Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Autacoids and Related Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Autacoids and Related Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Autacoids and Related Drugs Sales by Type (2015-2020) (K Units)
Table 35. North America Autacoids and Related Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Autacoids and Related Drugs Sales by Application (2015-2020) (K Units)
Table 37. North America Autacoids and Related Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Autacoids and Related Drugs Sales by Country (2015-2020) (K Units)
Table 39. Europe Autacoids and Related Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Autacoids and Related Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Autacoids and Related Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Autacoids and Related Drugs Sales by Type (2015-2020) (K Units)
Table 43. Europe Autacoids and Related Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Autacoids and Related Drugs Sales by Application (2015-2020) (K Units)
Table 45. Europe Autacoids and Related Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Autacoids and Related Drugs Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Autacoids and Related Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Autacoids and Related Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Autacoids and Related Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Autacoids and Related Drugs Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Autacoids and Related Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Autacoids and Related Drugs Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Autacoids and Related Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Autacoids and Related Drugs Sales by Country (2015-2020) (K Units)
Table 55. Latin America Autacoids and Related Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Autacoids and Related Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Autacoids and Related Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Autacoids and Related Drugs Sales by Type (2015-2020) (K Units)
Table 59. Latin America Autacoids and Related Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Autacoids and Related Drugs Sales by Application (2015-2020) (K Units)
Table 61. Latin America Autacoids and Related Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Autacoids and Related Drugs Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Autacoids and Related Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Autacoids and Related Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Autacoids and Related Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Autacoids and Related Drugs Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Autacoids and Related Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Autacoids and Related Drugs Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Autacoids and Related Drugs Sales Market Share by Application (2015-2020)
Table 70. Bedford Laboratories Corporation Information
Table 71. Bedford Laboratories Description and Major Businesses
Table 72. Bedford Laboratories Autacoids and Related Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. Bedford Laboratories Product
Table 74. Bedford Laboratories Recent Development
Table 75. Bristol-Myers Squibb Corporation Information
Table 76. Bristol-Myers Squibb Description and Major Businesses
Table 77. Bristol-Myers Squibb Autacoids and Related Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Bristol-Myers Squibb Product
Table 79. Bristol-Myers Squibb Recent Development
Table 80. APP Pharma Corporation Information
Table 81. APP Pharma Description and Major Businesses
Table 82. APP Pharma Autacoids and Related Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. APP Pharma Product
Table 84. APP Pharma Recent Development
Table 85. Abbott Laboratories Corporation Information
Table 86. Abbott Laboratories Description and Major Businesses
Table 87. Abbott Laboratories Autacoids and Related Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Abbott Laboratories Product
Table 89. Abbott Laboratories Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Major Businesses
Table 92. Sanofi Autacoids and Related Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Sanofi Product
Table 94. Sanofi Recent Development
Table 95. Chattem Corporation Information
Table 96. Chattem Description and Major Businesses
Table 97. Chattem Autacoids and Related Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Chattem Product
Table 99. Chattem Recent Development
Table 100. Xanodyne Corporation Information
Table 101. Xanodyne Description and Major Businesses
Table 102. Xanodyne Autacoids and Related Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Xanodyne Product
Table 104. Xanodyne Recent Development
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Major Businesses
Table 107. AstraZeneca Autacoids and Related Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. AstraZeneca Product
Table 109. AstraZeneca Recent Development
Table 110. Hospira Corporation Information
Table 111. Hospira Description and Major Businesses
Table 112. Hospira Autacoids and Related Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Hospira Product
Table 114. Hospira Recent Development
Table 115. Global Autacoids and Related Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 116. Global Autacoids and Related Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 117. Global Autacoids and Related Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 118. Global Autacoids and Related Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 119. North America: Autacoids and Related Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 120. North America: Autacoids and Related Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Europe: Autacoids and Related Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 122. Europe: Autacoids and Related Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Asia Pacific: Autacoids and Related Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 124. Asia Pacific: Autacoids and Related Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 125. Latin America: Autacoids and Related Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 126. Latin America: Autacoids and Related Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Middle East and Africa: Autacoids and Related Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 128. Middle East and Africa: Autacoids and Related Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 130. Key Challenges
Table 131. Market Risks
Table 132. Main Points Interviewed from Key Autacoids and Related Drugs Players
Table 133. Autacoids and Related Drugs Customers List
Table 134. Autacoids and Related Drugs Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Autacoids and Related Drugs Product Picture
Figure 2. Global Autacoids and Related Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Polypeptides Product Picture
Figure 4. Decarboxylated Amino Acids Product Picture
Figure 5. Eicosanoids Product Picture
Figure 6. Global Autacoids and Related Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Allergies
Figure 8. Inflammation
Figure 9. Gastric Acid Secretion
Figure 10. Neuroendocrine Regulation
Figure 11. Chronic Pain
Figure 12. Cardiovascular Diseases
Figure 13. Gastrointestinal Diseases
Figure 14. Autacoids and Related Drugs Report Years Considered
Figure 15. Global Autacoids and Related Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global Autacoids and Related Drugs Sales 2015-2026 (K Units)
Figure 17. Global Autacoids and Related Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Autacoids and Related Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Autacoids and Related Drugs Sales Market Share by Region in 2019
Figure 20. Global Autacoids and Related Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Autacoids and Related Drugs Revenue Market Share by Region in 2019
Figure 22. Global Autacoids and Related Drugs Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Autacoids and Related Drugs Revenue in 2019
Figure 24. Autacoids and Related Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Autacoids and Related Drugs Sales Market Share by Type (2015-2020)
Figure 26. Global Autacoids and Related Drugs Sales Market Share by Type in 2019
Figure 27. Global Autacoids and Related Drugs Revenue Market Share by Type (2015-2020)
Figure 28. Global Autacoids and Related Drugs Revenue Market Share by Type in 2019
Figure 29. Global Autacoids and Related Drugs Market Share by Price Range (2015-2020)
Figure 30. Global Autacoids and Related Drugs Sales Market Share by Application (2015-2020)
Figure 31. Global Autacoids and Related Drugs Sales Market Share by Application in 2019
Figure 32. Global Autacoids and Related Drugs Revenue Market Share by Application (2015-2020)
Figure 33. Global Autacoids and Related Drugs Revenue Market Share by Application in 2019
Figure 34. North America Autacoids and Related Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America Autacoids and Related Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Autacoids and Related Drugs Sales Market Share by Country in 2019
Figure 37. North America Autacoids and Related Drugs Revenue Market Share by Country in 2019
Figure 38. U.S. Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Autacoids and Related Drugs Market Share by Type in 2019
Figure 43. North America Autacoids and Related Drugs Market Share by Application in 2019
Figure 44. Europe Autacoids and Related Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Autacoids and Related Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Autacoids and Related Drugs Sales Market Share by Country in 2019
Figure 47. Europe Autacoids and Related Drugs Revenue Market Share by Country in 2019
Figure 48. Germany Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Autacoids and Related Drugs Market Share by Type in 2019
Figure 59. Europe Autacoids and Related Drugs Market Share by Application in 2019
Figure 60. Asia Pacific Autacoids and Related Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Autacoids and Related Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Autacoids and Related Drugs Sales Market Share by Region in 2019
Figure 63. Asia Pacific Autacoids and Related Drugs Revenue Market Share by Region in 2019
Figure 64. China Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Autacoids and Related Drugs Market Share by Type in 2019
Figure 87. Asia Pacific Autacoids and Related Drugs Market Share by Application in 2019
Figure 88. Latin America Autacoids and Related Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America Autacoids and Related Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Autacoids and Related Drugs Sales Market Share by Country in 2019
Figure 91. Latin America Autacoids and Related Drugs Revenue Market Share by Country in 2019
Figure 92. Mexico Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 95. Brazil Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 97. Argentina Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Autacoids and Related Drugs Market Share by Type in 2019
Figure 99. Latin America Autacoids and Related Drugs Market Share by Application in 2019
Figure 100. Middle East and Africa Autacoids and Related Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa Autacoids and Related Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Autacoids and Related Drugs Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Autacoids and Related Drugs Revenue Market Share by Country in 2019
Figure 104. Turkey Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Autacoids and Related Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E Autacoids and Related Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Autacoids and Related Drugs Market Share by Type in 2019
Figure 111. Middle East and Africa Autacoids and Related Drugs Market Share by Application in 2019
Figure 112. North America Autacoids and Related Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. North America Autacoids and Related Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Autacoids and Related Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Europe Autacoids and Related Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Autacoids and Related Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Asia Pacific Autacoids and Related Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Autacoids and Related Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Latin America Autacoids and Related Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Autacoids and Related Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Middle East and Africa Autacoids and Related Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
胃がん治療薬の世界市場（～2026年） Gastric cancer drugs are used to treat malignancies, or cancerous growths. The APAC region to account for the highest market share during the forecast period. Much of this region’s growth can be attributed to the increasing demand for better healthcare infrastructure, which results in its massive ma…- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- テネクテプラーゼ薬の世界市場（～2026年） Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug. It is estimated that North America dominated the…
- 爪囲炎治療薬の世界市場（～2026年） Paronychia usually happens when the skin around an individual's nail is irritated or harmed. Paronychia is a soft tissue infection of the skin around the fingernails and toenails. Bacteria which cause this type of infection are known as Candida. The infection begins as cellulitis but may progress to…
- 自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…